N/A Completed N=86 Randomized Other

Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment

Open-angle glaucoma

Source: ClinicalTrials.gov NCT03365778 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2020

Primary outcomePrimary: Completion of Selective Laser Trabeculoplasty (SLT) — 10; 6 Participants

Summary

The purpose of this study is to develop an educational program that will help improve the patients' understanding of what laser treatment is, how it might be beneficial to them, and why it should be the first eye pressure lowering glaucoma treatment to consider before the use of glaucoma eye drops.

Outcome Measures

Outcome	Result	p-value
PRIMARY Completion of Selective Laser Trabeculoplasty (SLT)	10; 6	—
PRIMARY Measure Educational Effects of Selective Laser Trabeculoplasty (SLT)	0; 0; 12; 0	—
SECONDARY Measure Educational Effects of Selective Laser Trabeculoplasty (SLT) Among Ophthalmologists	45	—

Eligibility Criteria

Inclusion Criteria

patients between 40 and 90 years of age
high-risk ocular hypertension, primary open-angle glaucoma, or pseudo-exfoliation glaucoma
currently treated with at least one glaucoma eye drop with stable intraocular pressure

Exclusion Criteria

previous laser trabeculoplasty
previous glaucoma surgery

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03365778). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.